Permax and neuroleptic malignant syndrome Patient Reports February 12, 2012

Permax Side Effects Report #5519302-0
Permax side effect was reported by a Physician from JAPAN on Nov 02, 2007. Male patient, 79 years of age, weighting 115.1 lb, was diagnosed with parkinson's disease  and was treated with Permax. After drug was administered, patient experienced the following side effects: altered state of consciousness, dehydration, hallucination, visual, neuroleptic malignant syndrome, somnolence, white blood cell count increased. Permax dosage: unknown. During the same period patient was treated with NEODOPASOL, RISPERIDINE. Patient was hospitalized. Patient recovered.

Permax Side Effects Report #4831111-4
Permax side effect was reported by a Consumer or non-health professional from JAPAN on Oct 21, 2005. Male patient, 79 years of age, was diagnosed with parkinson's disease  and was treated with Permax. After drug was administered, patient experienced the following side effects: hallucination, visual, neuroleptic malignant syndrome. Permax dosage: unknown. During the same period patient was treated with NEODOPASOL, RISPERIDONE. Patient was hospitalized. Patient recovered.

Permax Side Effects Report #5055299-8
Permax side effect was reported by a Pharmacist from JAPAN on July 05, 2006. Male patient, 64 years of age, was diagnosed with parkinson's disease  and was treated with Permax. After drug was administered, patient experienced the following side effects: cardiac disorder, condition aggravated, depressed level of consciousness, neuroleptic malignant syndrome. Permax dosage: unknown. During the same period patient was treated with LEVODOPA, PRAMIPEXOLE DIHYDROCHLORIDE, SELEGILINE HYDROCHLORIDE, AMANTADINE. Patient was hospitalized. Patient recovered.

Permax Side Effects Report #5278392-3
Permax side effect was reported by a Pharmacist from JAPAN on Mar 09, 2007. Male patient, 53 years of age, was diagnosed with parkinson's disease  and was treated with Permax. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, neuroleptic malignant syndrome, treatment noncompliance. Permax dosage: unknown. During the same period patient was treated with MADOPAR, OXETACAINE, ATARAX, VITANEURIN, PANTOL. Patient was hospitalized. Patient recovered.